Perinatal OutcomesPhase 3NCT00831831
Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?
A Phase 3 study testing Safety planning in people with Perinatal Outcomes, run by University of British Columbia at 1 site in Canada.
Trial summary
OBJECTIVE: To investigate if, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including antepartum hemorrhage or infection, low birthweight, and perinatal… Read more about this study
- Who is it for?
- Ages 18 to 35 years, women only
- Conditions the study is for
- Perinatal Outcomes
- What is being tested?
- Safety planning
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 0 participants
- Where
- 1 siteCanada
- Study dates
- Apr 2008to Dec 2011
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Pregnant
- Women
- Experiencing intimate partner violence
- Able to speak English or Punjabi.
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
OBJECTIVE: To investigate if, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including antepartum hemorrhage or infection, low birthweight, and perinatal death.
DESIGN: A randomized controlled trial. SETTING: Surrey Memorial Hospital and BC Women's Hospital in British Columbia, Canada PARTICIPANTS: Pregnant women experiencing intimate partner violence MAIN OUTCOME MEASURES: We are interested in perinatal outcomes such as birth weight and preterm labour.
DATA ANALYSIS: Outcomes for women in each arm of the trial will be compared in an intention to treat analysis. Changes in risk for adverse outcomes associated with the study intervention will be estimated by the odds ratios calculated by the logistic regression model.
Read the detailed description
Protocol RESEARCH PLAN
Title: Massage Therapy and Labour Outcomes: a Randomized Controlled Trial
- Goal and Objectives The overall purpose of this project is to evaluate whether or not, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including antepartum hemorrhage or infection, low birthweight, and perinatal death.
Specific Aims Our specific aim is to randomly assign women who identify as having been exposed to intimate partner violence to receive either usual care or a targeted safety planning intervention in order to study effect of safety planning on perinatal outcomes.
Research Questions
We will compare among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including:
- antepartum hemorrhage
- antepartum infection
- low birthweight
- perinatal death
Hypotheses We hypothesize that, among women who disclose exposure to intimate partner violence during pregnancy, those receive a targeted intervention of safety planning and referral will experience a reduction in incidence of low birthweight babies compared to those who receive standard care consisting of a resource card and the offer of referral to a social worker.
2.0 Design This is a randomized controlled trial. After providing informed, written consent, each participant will be randomly assigned to a) usual care or b) a targeted intervention program. Randomization will take place by pulling a consecutively numbered card from a box, within which a concealed allocation is written.
Study sample Our study sample will include pregnant women how indicate concern about intimate partner violence to their antenatal care providers at Surrey Memorial Hospital and BC Women's Hospital.
Study Setting The study will take place at Surrey Memorial Hospital an BC Women's Hospital in Vancouver, in British Columbia, Canada.
Recruitment During our proposed study, women who indicate to their antenatal provider that they are concerned about violence will be asked if they would like to receive some information about a study related to women's safety during pregnancy. If women are agreeable, the caregiver will provide them with a recruitment brochure. Women will sign their name on this brochure if they are interested and indicate how they would like to be contacted. A study research assistant will contact potential participants in a way that they have indicated is safe, and explain the study in detail.
Randomization Randomization will take place immediately after obtaining written consent. A statistical software package (SPSS - Statistical Program for the Social Sciences) will be utilized to randomly assign sequential numbers to one of the two treatment arms. Cards will be numbered sequentially and labelled with the treatment allocation. These cards will be placed in opaque envelopes in a box which will be kept in a locked cupboard to which the recruitment nurse holds the key. Envelopes will be opened in sequential order for each study participant after written informed consent has been obtained. A log book will be maintained by the research assistant detailing the patients approached, their decision to participate or not, randomization number, and allocation.
Protocol Usual care will consist of a resource card providing information about a variety of community agencies that support women, including women experiencing violence. and the opportunity to meet with a hospital social worker for referral to relevant community agencies.
The intervention program be provided by community health nurses and will consist of:
- ensuring that the woman has telephone numbers for community agencies serving women who experience violence, in particular, agencies that serve women of their cultural background with language-specific services; ii) knowledge of how to contact a women's shelter, and if desired, assistance in contacting the shelter and negotiating admission; iii) offer of referral to a hospital social worker with translation services available if necessary; iv) information on Canadian law with respect to violence perpetrated by an intimate partner; v) information on how to access outreach support to apply for welfare and/or skills assessment and retraining; vi) information on how to access outreach support to access emergency funds from a provincial employment and assistance program vii) safety planning, including a) identification of a method of escape from the home (a "rescue" driver, call to a shelter, taxi, extra set of car keys for family car); b) an "escape bundle" kept outside the home including important documents, money, etc.; c) identification of an escape route out of the house (unlatched window, for example); and d) recruitment of a friend or neighbour who can come over in the event that a code word is used over the phone.
Women will be asked to complete two measures of violence exposure at the time of enrollment and on a monthly basis thereafter.
Study Outcomes Our study outcomes include pregnancy complications and newborn outcomes. Pregnancy complications will include hemorrhage during the 2nd or 3rd trimester of pregnancy, intrauterine growth restriction, preterm labour (prior to 37 weeks), preterm delivery, and chorioamnionitis (infection of the placenta and membranes). Our primary newborn outcome is low birthweight (less than 2500g). Low birthweight will be further subdivided into preterm birth and/or birthweight within the 10th percentile for gestational age and sex by provincial standards. We will also document perinatal death.
- Conditions
- Perinatal Outcomes
- Being tested
- Safety planning
- Keywords
- perinatal, intimate partner violence, randomized controlled trial, preterm, hemorrhage, safety
- Medical subject headings
- Premature Birth, Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Safety planningBehavioural
See detailed description
What is being measured
The primary outcome is the main question the study is designed to answer.
Intrauterine Growth Restriction.
Measured: During pregnancy
Secondary outcomes (1)
Hemorrhage during the 2nd or 3rd trimester of pregnancy, preterm labour, preterm delivery, and chorioamnionitis.
Measured: During pregnancy
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2009 (estimated)
- Study startApr 2008
- Primary completionJan 2010
- Study completionDec 2011
Why it stopped: The team wasn't able to work effectively with the social worker at the site
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Perinatal OutcomesStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- Canadian Foundation for Women's Health
- Responsible party
- Sponsor
- Investigators
- Patti Janssen, Ph.D, Principal investigator, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00831831
- Sponsor's protocol ID
- H07-02007
- Status last verified
- Jul 2012
- First submitted
- 27 Jan 2009
- Last updated
- 12 Jul 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jul 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?
- ClinicalTrials.gov ID
- NCT00831831
- Acronym / sponsor ID
- H07-02007
- Conditions
- Perinatal Outcomes
- Keywords
- perinatal, intimate partner violence, randomized controlled trial, preterm, hemorrhage, safety
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: The team wasn't able to work effectively with the social worker at the site
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- Canadian Foundation for Women's Health
- Study start
- Apr 2008
- Primary completion
- Jan 2010 (actual)
- Study completion
- Dec 2011 (actual)
- First posted
- 29 Jan 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
OBJECTIVE: To investigate if, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including antepartum hemorrhage or infection, low birthweight, and perinatal death.
DESIGN: A randomized controlled trial. SETTING: Surrey Memorial Hospital and BC Women's Hospital in British Columbia, Canada PARTICIPANTS: Pregnant women experiencing intimate partner violence MAIN OUTCOME MEASURES: We are interested in perinatal outcomes such as birth weight and preterm labour.
DATA ANALYSIS: Outcomes for women in each arm of the trial will be compared in an intention to treat analysis. Changes in risk for adverse outcomes associated with the study intervention will be estimated by the odds ratios calculated by the logistic regression model.
Detailed description
Protocol RESEARCH PLAN
Title: Massage Therapy and Labour Outcomes: a Randomized Controlled Trial
- Goal and Objectives The overall purpose of this project is to evaluate whether or not, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including antepartum hemorrhage or infection, low birthweight, and perinatal death.
Specific Aims Our specific aim is to randomly assign women who identify as having been exposed to intimate partner violence to receive either usual care or a targeted safety planning intervention in order to study effect of safety planning on perinatal outcomes.
Research Questions
We will compare among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy services decrease rates of adverse perinatal outcomes including:
- antepartum hemorrhage
- antepartum infection
- low birthweight
- perinatal death
Hypotheses We hypothesize that, among women who disclose exposure to intimate partner violence during pregnancy, those receive a targeted intervention of safety planning and referral will experience a reduction in incidence of low birthweight babies compared to those who receive standard care consisting of a resource card and the offer of referral to a social worker.
2.0 Design This is a randomized controlled trial. After providing informed, written consent, each participant will be randomly assigned to a) usual care or b) a targeted intervention program. Randomization will take place by pulling a consecutively numbered card from a box, within which a concealed allocation is written.
Study sample Our study sample will include pregnant women how indicate concern about intimate partner violence to their antenatal care providers at Surrey Memorial Hospital and BC Women's Hospital.
Study Setting The study will take place at Surrey Memorial Hospital an BC Women's Hospital in Vancouver, in British Columbia, Canada.
Recruitment During our proposed study, women who indicate to their antenatal provider that they are concerned about violence will be asked if they would like to receive some information about a study related to women's safety during pregnancy. If women are agreeable, the caregiver will provide them with a recruitment brochure. Women will sign their name on this brochure if they are interested and indicate how they would like to be contacted. A study research assistant will contact potential participants in a way that they have indicated is safe, and explain the study in detail.
Randomization Randomization will take place immediately after obtaining written consent. A statistical software package (SPSS - Statistical Program for the Social Sciences) will be utilized to randomly assign sequential numbers to one of the two treatment arms. Cards will be numbered sequentially and labelled with the treatment allocation. These cards will be placed in opaque envelopes in a box which will be kept in a locked cupboard to which the recruitment nurse holds the key. Envelopes will be opened in sequential order for each study participant after written informed consent has been obtained. A log book will be maintained by the research assistant detailing the patients approached, their decision to participate or not, randomization number, and allocation.
Protocol Usual care will consist of a resource card providing information about a variety of community agencies that support women, including women experiencing violence. and the opportunity to meet with a hospital social worker for referral to relevant community agencies.
The intervention program be provided by community health nurses and will consist of:
- ensuring that the woman has telephone numbers for community agencies serving women who experience violence, in particular, agencies that serve women of their cultural background with language-specific services; ii) knowledge of how to contact a women's shelter, and if desired, assistance in contacting the shelter and negotiating admission; iii) offer of referral to a hospital social worker with translation services available if necessary; iv) information on Canadian law with respect to violence perpetrated by an intimate partner; v) information on how to access outreach support to apply for welfare and/or skills assessment and retraining; vi) information on how to access outreach support to access emergency funds from a provincial employment and assistance program vii) safety planning, including a) identification of a method of escape from the home (a "rescue" driver, call to a shelter, taxi, extra set of car keys for family car); b) an "escape bundle" kept outside the home including important documents, money, etc.; c) identification of an escape route out of the house (unlatched window, for example); and d) recruitment of a friend or neighbour who can come over in the event that a code word is used over the phone.
Women will be asked to complete two measures of violence exposure at the time of enrollment and on a monthly basis thereafter.
Study Outcomes Our study outcomes include pregnancy complications and newborn outcomes. Pregnancy complications will include hemorrhage during the 2nd or 3rd trimester of pregnancy, intrauterine growth restriction, preterm labour (prior to 37 weeks), preterm delivery, and chorioamnionitis (infection of the placenta and membranes). Our primary newborn outcome is low birthweight (less than 2500g). Low birthweight will be further subdivided into preterm birth and/or birthweight within the 10th percentile for gestational age and sex by provincial standards. We will also document perinatal death.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Pregnant
- Women
- Experiencing intimate partner violence
- Able to speak English or Punjabi.
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Safety planningSee detailed description | Behavioural | – |
Primary outcome
Intrauterine Growth Restriction.
Time frame: During pregnancy
1 secondary outcome
Hemorrhage during the 2nd or 3rd trimester of pregnancy, preterm labour, preterm delivery, and chorioamnionitis.
Time frame: During pregnancy
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jul 2012.
Related trials for Perinatal Outcomes
RecruitingObservational study
Long-Term Epilepsy Outcomes in Children With a History of Perinatal Stroke
Perinatal Stroke, Epilepsy
Recruiting
Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Meconium Exposure
Neonatal Respiratory Distress Related Conditions, Meconium
RecruitingObservational study
Mother and Offspring's Nutritional Status -Pregnancy After Maternal Bariatric Surgery
Bariatric Surgery, Pregnency
Recruiting
Deconstructing Maternal Burdens: Doulas and the Community Unite for Health
Pregnancy, Post Partum
Not yet recruitingObservational study
Study of Pregnancy in Patients With Myeloproliferative Neoplasms
Myeloproliferative Neoplasm (MPN), Pregnancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Patti Janssen, Ph.D principal investigator
University of British Columbia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Safety planning in people with Perinatal Outcomes, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 12 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intrauterine Growth Restriction. (time frame: During pregnancy). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2012.